Podcasts about related content association

Interview with Jayani Jayawardhana, PhD, author of Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning. Hosted by John Torous, MD, MBI. Related Content: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning

Interview with Jayani Jayawardhana, PhD, author of Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning. Hosted by John Torous, MD, MBI. Related Content: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning

A new JAMA study examines the association between severe maternal morbidity in a first birth and the probability of a subsequent birth. Authors Neda Razaz, PhD, and Eleni Tsamantioti, MD, MMedSc, both from the Karolinska Institute in Sweden, discuss this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH. Related Content: Association of Severe Maternal Morbidity With Subsequent Birth Severe Maternal Morbidity and Subsequent Birth—Understanding and Informing a Woman's Choice

Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. Armand, MD. Related Content: Association of New-Onset Seizures With SARS-CoV-2 Vaccines

Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. Armand, MD. Related Content: Association of New-Onset Seizures With SARS-CoV-2 Vaccines

Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. Armand, MD. Related Content: Association of New-Onset Seizures With SARS-CoV-2 Vaccines

Interview with Walter P. Weber, MD, author of Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer. Hosted by Amalia Cochran, MD. Related Content: Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

Interview with Walter P. Weber, MD, author of Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer. Hosted by Amalia Cochran, MD. Related Content: Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

JAMA Health Forum Editor John Ayanian, MD, MPP, and Associate Editor Julie Donohue, PhD, speak with Aaron S. Kesselheim, MD, JD, MPH, and Genevieve P. Kanter, PhD, about the role of advisory committees convened by the US Food and Drug Administration (FDA) to guide its decisions on whether to approve new prescription drugs. They also consider how the FDA has responded to recommendations from these advisory committees over the past decade. Related Content: Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021 The Real Question the FDA Is Asking Its Advisory Committees

Interview with Trine O. Eskesen, MD, PhD, and Jacob Steinmetz, MD, PhD, authors of Association of Trauma With Long-Term Risk of Death and Immune-Mediated or Cancer Disease in Same-Sex Twins. Hosted by Amalia Cochran, MD. Related Content: Association of Trauma With Long-Term Risk of Death and Immune-Mediated or Cancer Disease in Same-Sex Twins

Interview with Trine O. Eskesen, MD, PhD, and Jacob Steinmetz, MD, PhD, authors of Association of Trauma With Long-Term Risk of Death and Immune-Mediated or Cancer Disease in Same-Sex Twins. Hosted by Amalia Cochran, MD. Related Content: Association of Trauma With Long-Term Risk of Death and Immune-Mediated or Cancer Disease in Same-Sex Twins

Interview with Jenica N. Upshaw, MD, MS, author of Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma, and Ana Barac, MD, PhD, author of Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango. Hosted by Robert Bonow, MD. Related Content: Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango

Interview with Jenica N. Upshaw, MD, MS, author of Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma, and Ana Barac, MD, PhD, author of Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango. Hosted by Robert Bonow, MD. Related Content: Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango

Interview with Xin You Tai, MD, author of Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors. Hosted by Cynthia E. Armand, MD. Related Content: Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors

Interview with Xin You Tai, MD, author of Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors. Hosted by Cynthia E. Armand, MD. Related Content: Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors

Interview with Ziming Xuan, ScD, SM, and Alexander Y. Walley, MD, MSc, authors of Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities. Hosted by John Torous, MD, MBI. Related Content: Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities

Interview with Ziming Xuan, ScD, SM, and Alexander Y. Walley, MD, MSc, authors of Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities. Hosted by John Torous, MD, MBI. Related Content: Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities

In 2011, the US Food and Drug Administration (FDA) announced a mandate to limit acetaminophen (paracetamol) to 325 mg/tablet in combination acetaminophen and opioid medications, with manufacturer compliance required by early 2014. In this podcast, JAMA Deputy Editor Mary M. McDermott, MD, interviews Jayme E. Locke, MD, MPH, and Babak J. Orandi, MD, PhD, about their JAMA study describing results of the FDA announcement on subsequent rates of hospitalizations for acute liver failure due to toxicity from acetaminophen-containing opioid drugs. Related Content: Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure Moving the Needle to Reduce Acetaminophen (Paracetamol) Hepatotoxicity Acetaminophen (Paracetamol) and Acute Liver Failure

Interview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

Interview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

In this interview, JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with David A. Hyman, JD, MD, about the role of paid malpractice claims in the past as a predictor of future paid malpractice claims, including how this link applies to lower-risk and higher-risk medical specialties. Related Content: Association of Past and Future Paid Medical Malpractice Claims

Interview with Crisanto M. Torres, MD, MPH, and Joseph V. Sakran, MD, MPH, MPA, authors of Association of Whole Blood With Survival Among Patients Presenting With Severe Hemorrhage in US and Canadian Adult Civilian Trauma Centers. Hosted by Amalia Cochran, MD. Related Content: Association of Whole Blood With Survival Among Patients Presenting With Severe Hemorrhage in US and Canadian Adult Civilian Trauma Centers

Interview with Crisanto M. Torres, MD, MPH, and Joseph V. Sakran, MD, MPH, MPA, authors of Association of Whole Blood With Survival Among Patients Presenting With Severe Hemorrhage in US and Canadian Adult Civilian Trauma Centers. Hosted by Amalia Cochran, MD. Related Content: Association of Whole Blood With Survival Among Patients Presenting With Severe Hemorrhage in US and Canadian Adult Civilian Trauma Centers

Interview with Francis Vergunst, DPhil, and Massimilliano Orri, PhD, authors of Association of Childhood Externalizing, Internalizing, and Comorbid Symptoms With Long-term Economic and Social Outcomes. Hosted by Angel N. Desai, MD, MPH. Related Content: Association of Childhood Externalizing, Internalizing, and Comorbid Symptoms With Long-term Economic and Social Outcomes

Interview with Xingxing S. Cheng, MD, MS, author of Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes. Hosted by Rita Redberg, MD, and Rohini V. Kopparam, MD. Related Content: Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes

Interview with Xingxing S. Cheng, MD, MS, author of Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes. Hosted by Rita Redberg, MD, and Rohini V. Kopparam, MD. Related Content: Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes

Interview with Amrou Sarraj, MD, author of Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late Study. Hosted by Cynthia E. Armand, MD. Related Content: Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well

Interview with Amrou Sarraj, MD, author of Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late Study. Hosted by Cynthia E. Armand, MD. Related Content: Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well

Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD. Related Content: Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD. Related Content: Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Interview with Brian L. VanderBeek, MD, MPH, MSCE, author of Association of Treatment Type and Loss to Follow-up With Tractional Retinal Detachment in Proliferative Diabetic Retinopathy. Hosted by Neil Bressler, MD. Related Content: Association of Treatment Type and Loss to Follow-up With Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

Interview with Brian L. VanderBeek, MD, MPH, MSCE, author of Association of Treatment Type and Loss to Follow-up With Tractional Retinal Detachment in Proliferative Diabetic Retinopathy. Hosted by Neil Bressler, MD. Related Content: Association of Treatment Type and Loss to Follow-up With Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD. Related Content: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD. Related Content: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Interview with Jari Tiihonen, MD, PhD, author of Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. Hosted by John Torous, MD, MBI. Related Content: Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients

Interview with Jari Tiihonen, MD, PhD, author of Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. Hosted by John Torous, MD, MBI. Related Content: Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients

Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD. Related Content: Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities

Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD. Related Content: Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities

Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD. Related Content: Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities

In this Author Interview, JAMA Deputy Editor Gregory Curfman, MD, discusses the state of coronary artery bypass surgery in 2022 with E. Magnus Ohman, MD, from Duke University. The conversation emphasizes methods to preserve patency of saphenous vein bypass grafts, the subject of an article in the August 9, 2022, issue of JAMA. Dr Ohman wrote the accompanying Editorial. Related Content: Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery

Rishi K. Wadhera, MD, MPP, MPhil, Beth Israel Deaconess Medical Center, discusses his article investigating the association of the Medicare Hospital Value-Based Purchasing program with changes in patient care experience at safety-net vs non–safety-net hospitals with JAMA Health Forum editors John Z. Ayanian, MD, MPP, and Melinda B. Buntin, PhD. Related Content: Association of the Medicare Value-Based Purchasing Program With Changes in Patient Care Experience at Safety-net vs Non–Safety-net Hospitals

Observational data suggest that the risk of certain types of cancer may be increased in individuals with obesity and that this risk may be lower after bariatric surgery. JAMA Deputy Editor Gregory Curfman, MD, explores this in detail with Steven Nissen, MD, an author of a JAMA study on this topic, and Anita Courcoulas, MD, MPH, author of an accompanying editorial. Related Content: Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity Bariatric Surgery and Cancer Risk

Treatment strategies for acute ischemic stroke are continuing to evolve. JAMA Associate Editor and vascular neurologist Jeffrey Saver, MD, from the University of California Los Angeles, and JAMA Senior Editor Christopher Muth, MD, discuss 2 articles recently published in JAMA about alteplase in the treatment of acute ischemic stroke and provide a broader overview of the recent advances and future directions for the use of thrombolytics and endovascular thrombectomy for acute ischemic stroke.Treatment strategies for acute ischemic stroke are continuing to evolve. JAMA Associate Editor and vascular neurologist Jeffrey Saver, MD, from the University of California Los Angeles, and JAMA Senior Editor Christopher Muth, MD, discuss 2 articles recently published in JAMA about alteplase in the treatment of acute ischemic stroke, and provide a broader overview of the recent advances and future directions for the use of thrombolytics and endovascular thrombectomy for acute ischemic stroke. Related Content: Association of Recent Use of Non–Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase

JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with Manesh Patel, MD, about the latest trials and topics from the American Heart Association's Scientific Sessions meeting. Patel is chief of the division of cardiology at Duke University School of Medicine and this year's Scientific Sessions conference chair. Related Content: Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis